141 related articles for article (PubMed ID: 38107438)
21. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.
Lu J; Xu A; Wang J; Zhang L; Song L; Li R; Zhang S; Zhuang G; Lu M
BMC Health Serv Res; 2013 Jan; 13():37. PubMed ID: 23368750
[TBL] [Abstract][Full Text] [Related]
22. Analysis of hospitalization expenditures and influencing factors for inpatients with coronary heart disease in a tier-3 hospital in Xi'an, China: A retrospective study.
Ding JM; Zhang XZ; Hu XJ; Chen HL; Yu M
Medicine (Baltimore); 2017 Dec; 96(51):e9341. PubMed ID: 29390516
[TBL] [Abstract][Full Text] [Related]
23. Global budget payment system helps to reduce outpatient medical expenditure of hypertension in China.
Huang Y; Liu Y; Yang X; Li J; Fang P
Springerplus; 2016; 5(1):1877. PubMed ID: 27833836
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of admission characteristics, hospital length of stay and costs for cerebral infarction in a medium-sized city in China.
Ma Y; Liu Y; Fu HM; Wang XM; Wu BH; Wang SX; Peng GG
Eur J Neurol; 2010 Oct; 17(10):1270-6. PubMed ID: 20402751
[TBL] [Abstract][Full Text] [Related]
25. Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China.
Mao W; Tang S; Zhu Y; Xie Z; Chen W
Int J Equity Health; 2017 Oct; 16(1):180. PubMed ID: 29017542
[TBL] [Abstract][Full Text] [Related]
26. The impacts of diagnosis-intervention packet payment on the providers' behavior of inpatient care-evidence from a national pilot city in China.
Ding Y; Yin J; Zheng C; Dixon S; Sun Q
Front Public Health; 2023; 11():1069131. PubMed ID: 37325323
[TBL] [Abstract][Full Text] [Related]
27. Direct Medical Costs of Parkinson's Disease in Southern China: A Cross-Sectional Study Based on Health Insurance Claims Data in Guangzhou City.
Zhang H; Zhou W; Zhang D
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328925
[TBL] [Abstract][Full Text] [Related]
28. Costs of Hospitalization for Dementia in Urban China: Estimates from Two Urban Health Insurance Scheme Claims Data in Guangzhou City.
Zhang H; Zhang D; Yin Y; Zhang C; Huang Y
Int J Environ Res Public Health; 2019 Aug; 16(15):. PubMed ID: 31382609
[No Abstract] [Full Text] [Related]
29. Impacts of the Zero-Markup Drug Policy on Hospitalization Expenses of Patients with Stroke in Western China: An Interrupted Time Series Analysis.
Wu Y; Han X; Qiu J
Risk Manag Healthc Policy; 2024; 17():777-788. PubMed ID: 38584876
[TBL] [Abstract][Full Text] [Related]
30. Outpatient depression current care expenditure changes in Liaoning Province from 2015 to 2020: a study based on the "system of health accounts 2011".
Ma Y; Shi X; Sznajder KK; Zhao Y; Wan Q; Chai P; Yang X
Front Pharmacol; 2024; 15():1092580. PubMed ID: 38318143
[No Abstract] [Full Text] [Related]
31. [Analysis on disease burden and direct medical cost of Xueshuan Xinmaining Tablets in patients with cerebral infarction and coronary heart disease].
Hu J; Gao SQ; Wang J; Li J; Chen HW; Dai ZQ; Liao X
Zhongguo Zhong Yao Za Zhi; 2021 May; 46(9):2309-2316. PubMed ID: 34047135
[TBL] [Abstract][Full Text] [Related]
32. Economic burden of dengue fever in China: A retrospective research study.
Xu M; Chang N; Tu T; Sun J; Jiang J; Xia Y; Tang W; Ji H; Zhao X; Zhu J; Qi L; Liu X; Liu Q
PLoS Negl Trop Dis; 2022 May; 16(5):e0010360. PubMed ID: 35594296
[TBL] [Abstract][Full Text] [Related]
33. Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis.
Guo X; Xiao Y; Liu H; Li Q; Jiang Q; Liu C; Xie F; Wang H; Yang F; Han X; Yang H; Yang Y; Ye Y; Gan X; Long E
Front Public Health; 2023; 11():1079655. PubMed ID: 37188279
[TBL] [Abstract][Full Text] [Related]
34. Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data.
Li M; Wang F; Chen R; Liang Z; Zhou Y; Yang Y; Chen S; Ung COL; Hu H
Int J Chron Obstruct Pulmon Dis; 2018; 13():3349-3357. PubMed ID: 30349238
[TBL] [Abstract][Full Text] [Related]
35. Optimization of Diagnosis-Related Groups for 14,246 Patients with Uterine Leiomyoma in a Single Center in Western China Using a Machine Learning Model.
Ma Y; Li L; Yu L; He W; Yi L; Tang Y; Li J; Zhong Z; Wang M; Huang S; Xiong Y; Xiao P; Huang Y
Risk Manag Healthc Policy; 2024; 17():473-485. PubMed ID: 38444948
[TBL] [Abstract][Full Text] [Related]
36. The integration of urban and rural medical insurance to reduce the rural medical burden in China: a case study of a county in Baoji City.
Liu P; Guo W; Liu H; Hua W; Xiong L
BMC Health Serv Res; 2018 Oct; 18(1):796. PubMed ID: 30340575
[TBL] [Abstract][Full Text] [Related]
37. The impact of zero markup drug policy on patients' healthcare utilization and expense: An interrupted time series study.
Zhu Z; Wang J; Sun Y; Zhang J; Han P; Yang L
Front Med (Lausanne); 2022; 9():928690. PubMed ID: 36457568
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing the hospitalization cost for stroke patients in J district, Shanghai.
Chen C; Zhu B; Chen Y; Yang T; Li F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):628-638. PubMed ID: 35753733
[TBL] [Abstract][Full Text] [Related]
39. Effect of health insurance on direct hospitalisation costs for in-patients with ischaemic stroke in China.
Yong M; Xianjun X; Jinghu L; Yunyun F
Aust Health Rev; 2018 Feb; 42(1):39-44. PubMed ID: 28263706
[TBL] [Abstract][Full Text] [Related]
40. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
Zhang H; Zhang C; Zhu S; Ye H; Zhang D
BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
